Browse News
Filter News
Found 527,017 articles
-
As a valued member of our BioSpace community, we are eager to hear more from you and other readers. Name one influencer in the life sciences industry that produced a significant impact in 2018.
-
With a patient-centric focus, Ipsen Biopharmaceuticals is on a mission to improve patients’ lives, leveraging its global reach and placing a strategic focus on external innovation.
-
AstraZeneca is attempting to find encouraging news in the failure of its MYSTIC clinical trial, but it doesn’t look good.
-
When consumers have their genome tested by services like 23andMe and Ancestry.com, the companies hold the rights to the genetic information, which they often sell to biopharmaceutical companies. Nebula Genomics is taking a different approach.
-
If the company does sell some older assets, it could use the funds to support development of high-growth assets in immuno-oncology.
-
What did Dr. Victor Frankenstein use to bring his “monster” to life? Electricity. And as much as that seemed far-fetched when Mary Shelley wrote the novel in 1818, the use of electrical devices and electricity to treat diseases has advanced significantly—and continues to advance.
-
Two pharmaceutical companies and a medtech maker snagged three of the top-10 spots on Deloitte’s 2018 North America Technology Fast 500, a ranking of the fastest-growing North American companies in the fields of technology, life sciences, telecommunications, media and energy.
-
November 16 Research Roundup: Obesity and Pancreatic Cancer, the Mighty Mitochondria, and Weightl...
11/16/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
In announcing the round, Camel-IDS said the finances will be used for a phase Ib/II trial of its lead program CAM-H2, a treatment option in HER2-positive cancers, while further developing preclinical programs and broadening the pipeline.
-
7 Ways Sleep Deprivation Is a Career Killer
11/16/2018
Acute or chronic sleep deprivation affects more than just your personal life (or the number of coffees you need the next morning to get going). Lack of sleep can have significant consequences to your professional life and, over time, can hold you back from achieving your goals. -
8 Simple Ways to Organize Your Job Search
11/16/2018
If you’re applying for multiple jobs at the same time, perhaps over several weeks or months, things can quickly spiral out of control. You can easily find yourself with 10 or 20 different versions of your resume or cover letter floating around on your desktop, requests for materials coming at you... -
A summary of IPOs from companies in the biotech and pharma world since November 1, 2018.
-
Avanos Medical Presents New Preclinical Data Comparing the Outcomes of COOLIEF* Cooled Radiofrequency to Standard RF
11/16/2018
Avanos Medical, Inc. (NYSE: AVNS) presented new scientific research supporting the long-term effects seen in COOLIEF* Cooled Radiofrequency (RF) for the management of chronic pain at the 17th Annual American Society of Regional Anesthesia and Pain Medicine (ASRA) meeting.
-
Vyera Pharmaceuticals Receives FDA Clearance To Initiate A Phase 1 Study Of A New Chemical Entity Designed As A Potential Treatment For Toxoplasmosis
11/16/2018
Vyera Pharmaceuticals, LLC announced it plans to initiate a Phase 1 single ascending dose (SAD) study of VYR-006, a novel dihydrofolate reductase (DHFR) inhibitor which Vyera discovered and is developing for the treatment of toxoplasmosis.
-
AVITA Medical Announces Hiring of Full U.S. Sales Team of Experienced Burn Professionals to Support National Launch of RECELL® System
11/16/2018
Strong market response to the RECELL System approval in advance of U.S. launch with 32 burn centers actively reviewing the product or placing commercial orders
-
Vapotherm Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/16/2018
Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm”), today announced the closing of its initial public offering of 4,600,000 shares of common stock, at a price to the public of $14.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 600,000 shares of common stock
-
Autism Stories Launches as the World's First Video-On-Demand Platform Dedicated to Uniting the Autism Community
11/16/2018
In an effort to address the growing prevalence of autism and the desire to empower the global community affected, co-founders Remi Tetot and Alex Plank have launched Autism Stories,
-
Macula 30+ Eye Health Awarded as Best Healthy Aging Product
11/16/2018
Quantum Health, a leading provider of high-quality, science-based products that improve quality of life, is proud to announce that its Macula 30+™ has been named the Best Healthy Aging Product in the 2018 SupplySide CPG Editor's Choice Award program.
-
Battelle Awarded $14.6 Million Task Order to Support Defense Technical Information Center
11/16/2018
Battelle was awarded a five-year, $14.6 million task order by the U.S. Air Force Installation Contracting Agency (AFICA) under the Department of Defense Information Analysis Center’s (DoD IAC) Cyber Security Technical Area Task (CS TAT) Multi-Award Contract to support the Defense Technical Information Center (DTIC) in the development and enhancement of DTIC’s capabilities for search, discovery, and analysis of technical data and information.
-
Hunt Regional Medical Center Improving Patient Experience with Allen's Interactive Patient Engagement Solution
11/16/2018
Patients at Hunt Regional Medical Center in Greenville, Texas can now access industry leading interactive features on their patient-room televisions, thanks to the hospital's launch this month of Allen Technologies' E3 Patient Engagement Solution.